1. Introduction {#sec0005}
===============

Endoscopic retrograde cholangiopancreatography (ERCP) is today one of the most commonly performed minimally invasive procedures for the diagnosis and treatment of biliary and pancreatic diseases. Although it is a safe method, ERCP has the highest incidence of complications among upper gastrointestinal endoscopic procedures \[[@bib0005],[@bib0010]\], with complication rates ranging from 2.5%--8% when performed by experienced professionals \[[@bib0015], [@bib0020], [@bib0025]\].

Complications routinely described include acute pancreatitis (most common), acute cholangitis, hemorrhage, sepsis and cardiopulmonary changes \[[@bib0030], [@bib0035], [@bib0040], [@bib0045], [@bib0050]\]. However, there are some less common complications with high morbidity, such as duodenal perforation and hepatic subcapsular hematoma (HSH) \[[@bib0055], [@bib0060], [@bib0065], [@bib0070]\].

Regarding HSH, a extraluminal hemorrhagic complication with potential morbidity and mortality, there are 53 reports in literature, with a combined mortality rate of 7.5%, being 10 of those ruptured. The aim of this study is to perform a systematic review of HSH, an uncommon and high morbidity complication, and to report the case of a patient who presented with HSH after ERCP for choledocholithiasis treatment. The work has been reported in line with de SCARE criteria \[[@bib0075]\], and is approved by Santa Casa de São Paulo Research Ethics Committee number: 0897129.0.0000.5479.

2. Methods {#sec0010}
==========

A literature review was performed with the following descriptors: endoscopic retrograde cholangiopancreatography and hepatic subcapsular hematoma, in the following datebase: PubMed, scopus, BIREME.

Exclusion criteria was: articles that did not have at least an abstract available in one of the following languages: Italian, French, English and Portuguese. All articles were reviewed and data on cases with HSH rupture were analyzed separately.

The data was collected by two different authors, individually, and then analyzed, in case of any disagreement another author reviewed the original paper to minimize any error.

Of the initial 70 results, nine were excluded due to not being related to the research, 2 were excluded due to language and finally 5 were excluded due to not have at least an abstract available ([Chart 1](#fig0030){ref-type="fig"}).Chart 1Flowchart: review process.Chart 1

3. Case report {#sec0015}
==============

A 25-year-old female teacher, married, native to Argentina, with no comorbidities, BMI of 24, was admitted to with jaundice to the emergency department (Bilirubin 11.2 mg/dL), with secondary choledocholithiasis diagnosed by ultrasound (US) imaging. Abdominal US showed a normal-looking liver, dilated intra and extrahepatic biliary system, with 1.3 cm bile duct and 1.0 cm calculus inside, and ERCP was indicated for treatment. The procedure was successful, and calculus was removed with the help of guide wire and papillotomy, without complications. The gallbladder did not contrast during the exam.

The patient returned to the ward hemodynamically stable and asymptomatic. After 8 h of ERCP, she experienced sudden abdominal pain and pallor, laboratory tests and abdominal radiography showed significant gastric distension ([Fig. 1](#fig0005){ref-type="fig"}) and raised the hypothesis of blocked duodenal perforation, without pneumoperitoneum or complicated acute cholecystitis.Fig. 1Abdominal x-ray showing gastric distension.Fig. 1

Antibiotic therapy was initiated with ciprofloxacin 400 mg every 12 h and metronidazole 500 mg every 8 h, and a CT scan of the abdomen was performed and showed subcapsular hematoma of about 15 cm in diameter, affecting liver segments VI, VII and VIII, with air and a small amount of perihepatic free fluid ([Fig. 2](#fig0010){ref-type="fig"}). At this time, the patient presented with diffuse peritonitis on physical examination, and exploratory laparotomy was indicated.Fig. 2Abdominal CT showing HSH of about 15 cm, affecting liver segments 6, 7 and 8 with permeate air and small amount of perihepatic free liquid.Fig. 2

Intraoperatively, a minimal amount of hemoperitoneum, a gallbladder with thick and delaminated walls, and subcapsular hematoma affecting the right lobe of the liver with oozing bleeding in segment VI were identified ([Fig. 3](#fig0015){ref-type="fig"}). Patient was hemodynamically stable with 8.0 mg/dL hemoglobin (HB). Cholecystectomy and electrocautery hemostasis were performed in active bleeding, with apparent good final appearance, as well as a methylene blue test which ruled out duodenal perforation and cavity drainage. Postoperatively, after receiving 03 units of packed red blood cells, she maintained hemodynamic stability and was submitted to arteriography - in an attempt to identify the source of bleeding - with no signs of extravasation ([Fig. 4](#fig0020){ref-type="fig"}).Fig. 3Intraoperative photography showing discrete hemoperitoneum, enlarged liver with HSH affecting right lobe with bleeding segment VI.Fig. 3Fig. 4Arteriography with no signs of leakage.Fig. 4

On the fourth postoperative day (PO), she evolved with hemodynamic instability and 1500 mL of bloody outflow through the drain, and a new surgical approach was indicated. During the intraoperative period, moderate hemoperitoneum, subcapsular hematoma affecting the entire enlarged hepatic parenchyma, and hepatic bleeding in a laceration pattern were observed. Patient received 05 units of packed red blood cells and was submitted to argon-based hemostasis and tamponade with six compresses.

She remained intubated with ARDS (acute respiratory distress syndrome), maintaining a PaO2/Fio2 ratio of 60. Abdominal drainage was serosanguineous with an outflow rate of around 40 mL. After ventilatory improvement, a new laparotomy was performed, and compresses were removed. The liver was bruised on its entire surface, with no active bleeding, and enlarged (but smaller than in the previous approach). She was extubated on the 13th postoperative day and was discharged from the Intensive Care Unit (ICU) the following day, using antibiotics and pharmacologic venous thromboembolism prophylaxis.

In the ward, the patient had some isolated fever peaks, with no defined source, and maintained antibiotic therapy with ciprofloxacin and metronidazole. On the 20th postoperative day, the patient was asymptomatic, with normal leukogram and sustained hemoglobin levels ([Table 1](#tbl0005){ref-type="table"}). She underwent control a CT scan ([Fig. 5](#fig0025){ref-type="fig"}) on the 22nd postoperative day, which still showed hepatic hematoma, without free fluid, and with no sings of thrombosis. The abdominal drain was removed, and the hospital discharge was scheduled to the following day. At night, the patient was asymptomatic in the ward when she experienced sudden dyspnea and died. At necropsy, the findings were pulmonary embolism and venous thrombosis in the pelvic plexus.Table 1Hemoglobin controls during hospitalization.Table 1OR1° PO4° PO5° PO13° PO18° PO22° POHemoglobin (mg/dL)13.87.95.010.09.610.210.1Fig. 5CT showing persistence of hepatic hematoma, no free liquid.Fig. 5

4. Discussion {#sec0020}
=============

ERCP is an endoscopic procedure commonly performed since its introduction in 1968 \[[@bib0080]\] with established therapeutic and diagnostic utility. Its main indications are choledocholithiasis, biliary malignancies and benign or malignant pancreatic disorders \[[@bib0080], [@bib0085], [@bib0090]\].

The overall mortality rate of this procedure after diagnostic intervention is 0.2% \[[@bib0095]\] and after therapeutic procedure, 0.4--0.5% \[[@bib0070],\[[@bib0095],[@bib0100]\] and with complication rates ranging from 2.5--8%, with pancreatitis being the most common complication (1--7%), followed by acute cholangitis (1.4%), hemorrhage (1%), duodenal perforation (\<1%) \[[@bib0105]\] and cardiopulmonary complications (1%), such as arrhythmia, hypoxemia and aspiration \[[@bib0110]\]. Other less reported complications are: hepatic abscess formation, paralytic ileus, pneumothorax and pneumomediastinum \[[@bib0115],[@bib0120]\], HSH, among others.

Hepatic subcapsular hematoma is an extraluminal hemorrhagic complication secondary to ERCP, whose pathology is poorly understood and potentially life-threatening, requiring early identification and treatment. HSH after ERCP is a rare complication, but may be more frequent than previously thought \[[@bib0070],[@bib0125]\]. So far, 61 cases of HSH have been described in the literature, with 14 of them ruptured ([Table 5](#tbl0025){ref-type="table"}).

The incidence of this complication may be underestimated, since most patients have no symptoms and post-ERCP monitoring is uncommon \[[@bib0130],[@bib0135]\]. The first case was described in 2000 by Ortega et al. \[[@bib0140]\] and since then only a few isolated cases have been reported, including four (7.5%) death outcomes among them, demonstrating the potential severity of this condition.

The etiology of these hematomas is still unclear, and two hypotheses have been raised. The first one suggests that liver damage is secondary to the traction force exerted by the biliary duct extractor balloon when trying to remove a retained calculus. This force would cause the rupture of biliary vessels and branches, with subsequent bleeding \[[@bib0055],[@bib0145]\]. The second hypothesis, more commonly reported in the literature, suggests that the guidewire -- commonly used to cannulate the common bile duct -- would perforate it \[[@bib0125],[@bib0130],[@bib0150], [@bib0155], [@bib0160], [@bib0165]\], thus damaging the juxtaposed hepatic parenchyma, causing rupture of small intrahepatic vessels. Blood filtration through the hepatic parenchyma, which follow a centrifugal pattern and the presence of a solid capsule would justify the presence of air in the hematoma and thus the pathophysiology. The high frequency of infection would be justified by the use of a guide wire without sterilization \[[@bib0170]\].

In the literature review conducted in this study, of the 61 cases analyzed, 49 reported the use of guidewire in the procedure (80.3%), while 12 of them made no mention of its use or not (19.7%).

Clinical manifestations of HSH are varied, including abdominal pain, shoulder pain, anemia, fever, and signs of hypotension. The literature review of this study showed that the most frequent clinical manifestation is abdominal pain (82.0%) followed by anemia (55.7%), hypotension (27.9%), fever (18.0%), and shoulder pain (13.1%) ([Table 2](#tbl0010){ref-type="table"}) which corroborates the data obtained by Zizzo et al. \[[@bib0170]\] and Zappa \[[@bib0175]\].Table 2Sings and symptoms.Table 2Signs and symptomsAbdominal pain83.3% (50)Anemia56.7% (34)Hypotension28.3% (17)Fever18.3% (11)Shoulder pain13.3% (8)

The onset of these symptoms, associated with subsequent or immediate hypotension, is suggestive of the presence of HSH. Their manifestation may occur from hours to days after the procedure \[[@bib0025],[@bib0180]\]. Our study revealed that 77.8% of clinical manifestations begin within 48 h (42 cases), 53.7% within 24 h (29 cases) and 40.7% within 12 h (22 cases), with a peak incidence 48 h after the procedure (12 cases, corresponding to 22.2%).

When analyzing the time of onset the HSH rupture cases shows a significant reduction in the median time 12 h (1--96 h) compared to 27 h (2 h -- 15 days) in the HSH and average time, as in the average time 25.5 h HSH rupture group and 69,4 h HSH ([Table 3](#tbl0015){ref-type="table"}).Table 3HSH x HSH rupture.Table 3HSH ruptureHSHCases14 cases45 casesAverage time before symptoms25.5 h69.4 hMedian time before symptoms12 h (1--96 h)27 h (2 h -- 15 days)Guidewire12 (85.7%)36 (80.0%)Basket1 (7.1%)\--Mortality3 (21.4%)1 (2.2%)

The most predominant diagnostic methods for HSH are CT (91.4%) and US (22.4%). In the reported case, the patient experienced abdominal pain, the most frequently described symptom, and anemia 8 h after ERCP, with abdominal CT.

By analyzing only the subgroup of patients who had HSH rupture, we detected a significant increase in the mortality rate compared to non-ruptured (21.4% × 2.2%), even though the rupture subgroup was only 23.7% of the total number of cases reported in the literature. We also detected that patients with rupture required some type of intervention, of which 78.6% required surgery ([Table 3](#tbl0015){ref-type="table"}).

The is a predominance HSH in right the lobe (87.3%) with 5.5% of the cases affecting both lobes; we also perform a statistic analyze, using Fisher\'s exact test, and no associations between death and the affected liver lobe side (p = 0.256) were verified.

Treatment should be customized on a case-by-case basis, but antibiotic therapy is always recommended due to the high risk of infection \[[@bib0060],[@bib0125]\]. Hemodynamically stable patients with limited, non-compressive superficial hematoma can be managed conservatively \[[@bib0060]\]. Glisson's capsule of the liver maintains hematoma stability and limits bleeding. In this approach, patient management consists of intravenous fluid infusion and replacement of blood derivatives, serial monitoring of hemoglobin concentration, serial hepatic function tests, repeated physical examination, rest and intensive care unit observation \[[@bib0015],[@bib0125],[@bib0140],[@bib0185]\].

In addition, monitoring hematoma progression with imaging such as CT and US is the optimal approach. Whenever there is hemodynamic instability with active bleeding and contrast extravasation, immediate surgical or radiological approach should be considered \[[@bib0175]\].

Surgical treatment should be considered when patient's general conditions becomes deteriorated, when there is hemodynamic instability, signs of peritoneal irritation, infected hematoma, findings of abdominal free fluid on CT \[[@bib0020]\] and complications, such as hematoma rupture \[[@bib0170],[@bib0190], [@bib0195], [@bib0200]\]. In this case, the procedure consists of hematoma drainage, hemostasis with electrocauterization or hemostatic devices -- if possible -- and follow-up with imaging exams.

Should active bleeding and hemodynamic instability insue, it is reported in the literature that arteriography with bleeding source embolization has been used to control bleeding with satisfactory results \[[@bib0055],[@bib0125],[@bib0135],[@bib0145]\]. Embolization by percutaneous angiography of a branch of the hepatic artery also proved to be an effective non-surgical treatment option \[[@bib0200]\].

A review of the literature revealed the predominance of conservative treatment (39.3%), followed by surgical approach (27.9%), percutaneous hematoma drainage (22.95%), and, finally, embolization treatment (8.2%) ([Table 4](#tbl0020){ref-type="table"}).Table 4Treatment.Table 4TreatmentSurgery1727.9%Conservative2439.3%Percutaneous Drainage1422.95%Percutaneous Drainage + Embolization11.6%Embolization58.2%Table 5Review of the literature.Table 5Author (Year)ERCP IndicationGuidewireSymptoms Onset TimeSings and SyntomsRuptureDiagnosis MethodHematoma LocationTreatmentDeathOrtega et al. \[[@bib0140]\] (2000)CholedocolitiasisYes---Abdominal Pain---------Percutaneous DrainageNoBhandarkar et al. \[[@bib0205]\] (2004)CholedocolitiasisYes10 daysAbdominal Pain, Anemia, Nausea and PyrexiaNoComputed TomographyRight Lobe (Segments V and VI)Percutaneous DrainageNoChi et al. \[[@bib0125]\] (2004)Pancreatic NeoplasmYes5 hAbdominal Pain and AnemiaYesComputed TomographyRight LobeEmbolizationNoHorn et al. \[[@bib0130]\] (2004)Pancreatic AdenocarcinomaYes48 hAbdominal Pain and AnemiaNoComputed Tomography---ConservativeNoErtugrul et al. \[[@bib0065]\] (2006)Hilar CholangiocarcinomaYes48 hAbdominal Pain, Anemia and PyrexiaNoComputed Tomography and UltrasonographyRight lobe (Segment V)ConservativeNoBhati et al. \[[@bib0165]\] (2007)CholedocolitiasisYes---Abdominal Pain and HypotensionYesComputed TomographyRight LobePercutaneous DrainageNoDel Rossi et al. \[[@bib0210]\] (2007)CholedocolitiasisYes48 hAbdominal Pain, Anemia and HypotensionNoComputed Tomography and UltrasonographyRight LobeConservativeNoPapachristou et al. \[[@bib0215]\] (2007)Hilar CholangiocarcinomaYes48 hAbdominal Pain, Anemia and Shoulder Pain---Computed TomographyRight LobeConservative---Petit-Laurent et al. \[[@bib0220]\] (2007)CholedocolitiasisYes48 hAbdominal Pain, Asthenia and PyrexiaNoComputed Tomography and UltrasonographyRight Lobe (Segment VIII)Percutaneous DrainageNoPriego et al. \[[@bib0200]\] (2007)CholedocolitiasisYes---Abdominal Pain, Hypotension, Nausea, Shoulder Pain and TachypneaNoComputed TomographyRight LobeSurgeryNoCárdenas et al. \[[@bib0155]\] (2008)Biliary Fistula after Liver TransplantYes24 hAbdominal Pain and AnemiaNoComputed Tomography and UltrasonographyLeft LobeConservativeNoDe La Serna - Higuera et al. \[[@bib0225]\] (2008)CholedocolitiasisYes48 hAbdominal Pain and LeukocytosisNoComputed Tomography and UltrasonographyRight LobePercutaneous DrainageNoDe Mayo et al. \[[@bib0230]\] (2008)Ampullary TumorYes4 hShoulder PainNoComputed TomographyRight LobeConservativeNoMcArthur et al. \[[@bib0160]\] (2008)CholedocolitiasisYes12 hAbdominal Pain and LeukocytosisNoComputed TomographyRight LobeConservativeNoNari et al. \[[@bib0235]\] (2009)Acute Biliary PancreatitisYes---Abdominal Pain, Anemia, Nausea Pyrexia, Tachycardia, Tachypnea and VomitsNoComputed Tomography and UltrasonographyRight LobeConservativeNoYriberry Urena et al. \[[@bib0240]\] (2009)CholedocolitiasisYes48 hAnemiaYesComputed TomographyRight LobeSurgeryNoRevuelto Rey et al. \[[@bib0245]\] (2010)CholedocolitiasisYes6 hAnemiaNoComputed TomographyRight LobeConservativeNoSaa et al. \[[@bib0250]\] (2010)CholedocolitiasisYes24 hHypotension and Upper Gastrointestinal BleedingNoComputed TomographyLeft LobeSurgeryYesBaudet et al. \[[@bib0145]\] (2011)CholedocolitiasisYes48 hAbdominal Pain, Anemia, Hypotension and PyrexiaYesComputed Tomography and UltrasonographyRight Lobe (Segments VI, VII e VIII)Embolization and SurgeryNoDel Pozo et al. \[[@bib0060]\] (2011)CholedocolitiasisYes5 daysAbdominal Pain and AnemiaNoComputed TomographyLeft Lobe and Right LobeConservativeNoManikam et al. \[[@bib0255]\] (2011)CholedocolitiasisYes14 hAbdominal Pain, Pyrexia and Thoracic PainNoComputed TomographyRight lobe (Segment VIII)Percutaneous DrainageNoPérez - Legaz et al. \[[@bib0195]\] (2011)CholedocolitiasisYes2 hAbdominal Pain, Anemia, Hypotension, Tachycardia and TachypneaYesComputed TomographyRight Lobe (Segments V e VI)Surgery with ElectrocauterizationNoShah et al. \[[@bib0260]\] (2011)Benign Anastomotic StenosisYes------No------ConservativeNoWeilert et al. \[[@bib0265]\] (2011)CholedocolitiasisYes24 hAbdominal PainNoComputed Tomography---ConservativeNoBartolo Rangel et al. \[[@bib0270]\] (2012)Choledocolitiasis---24 hAcute Abdomen and ShockYesThoracic Radiography and Intraoperative---SurgeryYesOrellana et al. \[[@bib0055]\] (2012)Ampullary Tumor---4 hShoulder PainNoComputed TomographyRight LobeConservativeNoBiliary Stent Exchange---2 hAbdominal Pain, Hypotension and TachycardiaYesComputed TomographyRight LobeEmbolization and Percutaneous DrainageNoBiliary Stent Exchange------Abdominal Pain and Shoulder PainNoComputed TomographyRight LobeConservativeNoFei et al. \[[@bib0020]\] (2013)CholedocolitiasisYes2 hPyrexiaNoComputed TomographyRight LobePercutaneous DrainageNoKlímová et al. \[[@bib0135]\] (2013)CholedocolitiasisYes6 hAbdominal Pain and AnemiaNoComputed TomographyRight LobeEmbolization, Percutaneous Drainage and SurgeryNoOliveira Ferreira et al. \[[@bib0275]\] (2013)CholedocolitiasisYes10 daysAbdominal Pain and AnemiaNoComputed Tomography and UltrasonographyRight LobePercutaneous DrainageNoPatil et al. \[[@bib0280]\] (2013)CholedocolitiasisYes48 hAbdominal PainNoComputed Tomography and UltrasonographyRight LobePercutaneous DrainageNoCarrica et al. \[[@bib0285]\] (2014)CholedocolitiasisYes72 hAbdominal Pain and AnemiaNoMagnetic Resonance Imaging and UltrasonographyRight Lobe (Segments VII and VIII)Percutaneous DrainageNoYoshii et al. \[[@bib0290]\] (2014)Choledocolitiasis---30 hAbdominal PainNoComputed TomographyRight LobeConservativeNoGonzáles - López et al. \[[@bib0295]\] (2015)Benign Choledoco Stenosis and Biliary Stent ExchangeYes72 hAbdominal Pain, Anemia, Hypotension and PeritonitisYesComputed TomographyRight LobeSurgeryYesZizzo et al. \[[@bib0170]\] (2015)CholedocolitiasisYes24 hAbdominal Pain, Anemia, Hypotension and Shoulder PainNoAngiography and Computed TomographyRight LobeEmbolizationNoCurvale et al. \[[@bib0300]\] (2016)Papilary AdenomaYes1 hAbdominal Pain, Anemia, Chills, Hypotension and Shoulder PainYesComputed TomographyRight LobeSurgeryNoDing Shi et al. \[[@bib0305]\] (2016)CholedocolitiasisYes16 hAbdominal Pain and AnemiaNoComputed TomographyRight LobeConservativeNoFiorini et al. \[[@bib0310]\] (2016)CholedocolitiasisYes8 hAbdominal Pain and PyrexiaNoComputed TomographyLeft Lobe (Segment II)Percutaneous DrainageNoKilic et al. \[[@bib0315]\] (2016)CholedocolitiasisYes12 hAbdominal Pain, Anemia, Fatigue and HypotensionYesComputed Tomography and UltrasonographyLeft Lobe and Right LobeSurgeryNoKisaoglu et al. \[[@bib0320]\] (2016)CholedocolitiasisYes2 hAbdominal Pain and Right Pleural EffusionNoThoracic Computed TomographyRight LobeSurgeryNoServide et al. \[[@bib0180]\] (2016)Choledocolitiasis---15 daysAbdominal PainNoComputed TomographyRight Lobe (Segments IV e VIII)ConservativeNoSolmaz et al. \[[@bib0325]\] (2016)CholedocolitiasisYes6 hAbdominal Pain, Back Pain, Breathing Acidosis, Pyrexia and Shoulder PainNoComputed TomographyRight LobeConservativeNoTamez et al. \[[@bib0330]\] (2016)CholedocolitiasisYes12 hAbdominal Pain and AnemiaYesUltrasound and Upper Digestive EndoscopyRight LobeSurgeryNoZappa et al. \[[@bib0175]\] (2016)CholedocolitiasisYes12 hAbdominal Pain, Anemia, Hypotension and TachycardiaNoComputed TomographyRight Lobe (Segments VI e VII)EmbolizationNoZela et al. \[[@bib0335]\] (2016)Choledocolitiasis---10 daysAbdominal PainNoUltrasonographyRight LobeConservativeNoCorazza et al. \[[@bib0070]\] (2017)CholedocolitiasisYes2 hAbdominal Pain and AnemiaNoComputed TomographyRight Lobe (Segments IV, V, VI, VII and VIII)SurgeryNoDel-Moral Martinez et al. \[[@bib0025]\] (2017)Choledocolitiasis---6 hAbdominal Pain, Anemia, Hypotension and TachycardiaNoComputed TomographyLeft Lobe and Right LobeConservativeNoCholedocolitiasis---7 daysAbdominal Pain, Anemia and PyrexiaNoComputed Tomography and UltrasonographyLeft Lobe (Segment III)Percutaneous DrainageNoDe La Maza Ortiz et al. \[[@bib0340]\] (2018)CholedocolitiasisYes4 hAnemia and HypotensionNoComputed TomographyRight LobeConservativeNoCholedocolitiasisYes2 hAbdominal Pain, Anemia and HypotensionNoAngiography and Computed TomographyRight LobeEmbolizationNoImperatore et al. \[[@bib0345]\] (2018)Benign Biliary Stenosis and Biliary Stent ExchangeYes2 hAbdomina Pain, Pyrexia and Thoracic PainYesComputed TomographyRight LobeSurgeryNoCholedocolitiasisYes48 hAbdominal PainNoComputed TomographyRight LobeEmbolizationNoSoler Humanes et al. \[[@bib0350]\] (2018)Choledocolitiasis------Abdominal Pain and AnemiaNoComputed TomographyRight LobePercutaneous DrainageNoYang et al. \[[@bib0355]\] (2018)CholedocolitiasisYes96 hAbdominal Distension, Abdominal Pain, Anemia and PyrexiaYesComputed TomographyRight LobePercutaneous Drainage and SurgeryNoLavall da Silva et al. \[[@bib0360]\] (2019)Duodenal Papila Stenosis---9 daysAbdominal Pain, Anemia and JaundiceNoComputed TomographyRight Lobe (Segments V, VI, VII and VIII)ConservativeNoSommariva et al. \[[@bib0365]\] (2019)CholedocolitiasisYes48 hAbdominal Pain and AnemiaNoComputed TomographyRight Lobe (Segments VI, VII and VIII)ConservativeNoSotelo et al. \[[@bib0370]\] (2019)CholedocolitiasisYes96 hAbdominal Pain and DyspneaNoComputed TomographyRight LobePercutaneous DrainageNoVillavicencio et al. \[[@bib0375]\] (2019)---Yes48 hAbdominal Pain, Anemia and HypotensionNoComputed TomographyRight Lobe (Segments IV and VII)SurgeryNo------15 days---No------ConservativeNoCase ReportCholedocolitiasisYes8 hAbdominal Pain and AnemiaYesCTRight Lobe (Segments VI, VII and VIII)SurgeryYes

5. Conclusion {#sec0025}
=============

Hepatic subcapsular hematoma is a potentially fatal post-ERCP complication and should be considered as differential diagnosis of symptomatic post-procedure cases.
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